Large-scale testing (Phase 3)Study completedNCT05916326
What this trial is testing
Phase III Clinical Trial to Evaluate the Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine,Recombinant (Hansenula Polymorpha)
Who this might be right for
Norovirus InfectionsNorwalk Gastroenteritis
National Vaccine and Serum Institute, China 8,000